Eric Knight

Eric Knight

Company: Ultragenyx Pharmaceutical

Job title: Head of Global EHS


Navigating Complex Safety Challenges in Research & Development of Advanced Cell & Gene Therapies 9:30 am

Despite the success and clinical promise of advanced cell and gene therapies, a set of unique safety challenges are unveiled. In this dynamic and interactive workshop, delve into strategies for overcoming the complex set of safety challenges to ensure the well-being of your workers despite uncertainties and contribute to the safe advancement of revolutionary therapies.…Read more

day: Pre-Conference Day

Strategies for Nurturing a Safety-Minded Culture in Occupational Health & Safety in Research & Development 9:00 am

• Defining a safety-minded culture in higher risk environments from biologics and virus  • Emphasizing the vital role of training in development of a safety-first culture in  occupational health and safety raising awareness of biohazards  • Strategies to identify specific gaps in skills and knowledge to generate custom training programs relative to your drug developmentRead more

day: Day Two

Presentation Q&A & Panel Discussion: A Holistic View of Safety & Best-Practices for Implementing a Safety-First Culture 10:00 am

This interactive Q&A session allows you to participate in a constructive dialogue, ask your most pressing questions, and engage with our expert speakers following their presentations on safety-first culture. Whether you seek clarification, want to  explore a topic further, or simply desire their expert opinion, this is your chance to get involved in this dynamic exchange…Read more

day: Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.